Skip to main content
. Author manuscript; available in PMC: 2022 Apr 14.
Published in final edited form as: Curr Med Chem. 2020;27(9):1420–1443. doi: 10.2174/0929867326666190805151654

Table 6.

Known antiviral activities of LL-37.

Virus CMV HSV-1 HSV-2 KSHV VZV Vaccinia HAdV A B C D E F HPV
LL-37 U Increase IFNB expression, inhibit virus binding U Disrupt envelope, prevent viral entrance U Disrupt envelope * NE NE U NE * U
Virus (con.) DENV HCV VEEV Aichivirus A Echovirus HRV Influenza A virus HPIV RSV VHSV VSV HIV-I
LL-37 Binding to envelope protein Disrupt enve lope U U * U Disrupt envelope, increase neutrophil NET * Disrupt envelope, prevent viral exit * * Inhibits reverse transcriptase

NE: Tested HDP had no effect, U: Antiviral mechanism is undetermined,

*:

Yet to be tested.

Table shows most common result of HDP antiviral test.